Traws Pharma, Inc. (TRAW) News
Track canonical SquawkNews coverage tagged to TRAW, Traws Pharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
TRAW - Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
TRAW - Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
EARNINGS | Aug 14, 2026, 08:30 PM UTC
L
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
EQUITY | Jul 02, 2026, 01:18 PM UTC
L
Traws PharmaFiles Prospectus For Mixed Shelf Offering Of Up To ~$139.2M
Traws Pharma, Inc. $139,185,641.25 Common Stock Preferred Stock Debt Securities Warrants Units This prospectus covers our offer and sale from time to time of any combination of common stock, preferred stock, debt securit
EQUITY | Jul 01, 2026, 08:05 PM UTC
M
TRAW Updates Guidance
Traws Pharma provides updated guidance on influenza prophylaxis program with resubmission of data package to MHRA expected in 3Q 2026
EQUITY | Jun 22, 2026, 11:01 AM UTC